|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
9
|
|
pubmed:dateCreated |
1991-3-19
|
|
pubmed:abstractText |
The concentrations of teicoplanin in sera and heart tissues of 49 patients undergoing coronary bypass were measured. Each patient received a 6- or 12-mg/kg dose of teicoplanin administered in a slow intravenous bolus injection over 3 to 5 min beginning at the time of induction of anesthesia. Mean +/- standard error of the mean concentrations in serum were, for the two doses, respectively, 58.1 +/- 1.7 and 123.3 +/- 7.4 micrograms/ml 5 min after administration and 22.2 +/- 0.7 and 56.5 +/- 2.8 micrograms/ml at the time of removal of atrial appendages. Mean +/- standard error of the mean concentrations in tissue were 70.6 +/- 1.7 and 139.8 +/- 2.2 micrograms/g, respectively, giving mean tissue/serum ratios of 3.7 +/- 0.3 and 2.8 +/- 0.2, respectively. Teicoplanin penetrates heart tissue readily and reaches levels in the serum far in excess of the MICs for most pathogens that have been found to cause infections following open heart surgery.
|
|
pubmed:commentsCorrections |
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-2846489,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-2963586,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-2966139,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-2966140,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-2970950,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-3458701,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-354521,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-3571052,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-4026265,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-6213192,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-6227280,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-6227282,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-6240962,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-6965578,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-7114627,
http://linkedlifedata.com/resource/pubmed/commentcorrection/2149493-7450932
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Sep
|
|
pubmed:issn |
0066-4804
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
34
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1699-702
|
|
pubmed:dateRevised |
2009-11-18
|
|
pubmed:meshHeading |
pubmed-meshheading:2149493-Anti-Bacterial Agents,
pubmed-meshheading:2149493-Cardiopulmonary Bypass,
pubmed-meshheading:2149493-Dose-Response Relationship, Drug,
pubmed-meshheading:2149493-Female,
pubmed-meshheading:2149493-Glycopeptides,
pubmed-meshheading:2149493-Heart Atria,
pubmed-meshheading:2149493-Humans,
pubmed-meshheading:2149493-Injections, Intravenous,
pubmed-meshheading:2149493-Male,
pubmed-meshheading:2149493-Myocardium,
pubmed-meshheading:2149493-Teicoplanin
|
|
pubmed:year |
1990
|
|
pubmed:articleTitle |
Concentrations of teicoplanin in serum and atrial appendages of patients undergoing cardiac surgery.
|
|
pubmed:affiliation |
Laboratoire et Service d'Infectiologie, Le Centre Hospitalier de l'Université Laval, Ste-Foy, Quebec, Canada.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Controlled Clinical Trial,
Research Support, Non-U.S. Gov't
|
